UF Pharmacy faculty receive NCI grant to study early-stage pancreatic cancer therapeutic
The team will assess whether a new therapeutic can intercept cellular processes before pancreatic cancer develops.
All Posts by
The team will assess whether a new therapeutic can intercept cellular processes before pancreatic cancer develops.
The discovery could have implications for cancer, the aging process, and growth and development.
Rachel Newsome won for her research targeting the gut microbiome in lung cancer patients to improve their immune response.
The Rising Star Award recognizes exceptional early-career clinical faculty whose actions and activities consistently exemplify clinical excellence.
Two oncologists were honored for their work on clinical trials for adolescent and young adult patients with cancer.
The study found Black and Hispanic people had higher rates of initiation and Black people had higher rates of subsequent use.
Mansi Dalal, M.D., is one of the Cancer Center's clinical investigators who has dedicated her career to developing better cancer treatments.
In an interview with OncLive, Burak Zeybek, M.D., discusses the phase 1 NOW trial investigating neoadjuvant olaparib in patients with ovarian cancer.
Cancer center leaders, physicians and investigators — many whose research has been funded through FACCA — attended this year’s retreat.
Using real-world data, the study is the first to provide evidence of a positive association between asthma and cancer risk in U.S. patients.